Altis Biologics

Altis Biologics (Pty) Ltd has developed, the Osteogenic Bone Matrix (OBM). The device obviates the need for painful and costly autograft harvesting procedures during orthopedic surgery by synergistically working with the bodies’ own cells the regenerate and form new healthy human bone.

Website :

Call 2018

The 2018 call for applications for the Young Enterprise Initiative – Start in France is now closed for Finnish, Italian, South Korean, Taiwanese, and U.S. companies. The call will open soon for South African companies.

Country Programs



Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links